CrushSCI.com
92.0平均天数
73.5中位天数
1最短天数
375最长天数
1322025发文量

Paper Review Records

全部论文审稿周期

22 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

375 天

CXCL12 + LSEC–CXCR4 + CAF axis drives post-transplant hepatocellular carcinoma recurrence under tacrolimus immunosuppression

作者
Tomohiko Ikehara; Masaya Onishi; Takeo Toshima; Taro Tobo; Hiroko Oshima; Kiyotaka Hosoda; Takashi Ofuchi; Akinori Tsujimoto; Yu Takahashi; Koto Kawata; Shohei Shibuta; Yuki Ando; Qingjiang Hu; Yusuke Yonemura; Akira Shimizu; Hajime Otsu; Masanobu Oshima; Yutaka Suzuki; Takaaki Masuda; Yuka Fujimoto; Kiyoshi Hasegawa; Tomoharu Yoshizumi; Yuji Soejima; Koshi Mimori展开收起
作者单位
1. Department of Surgery, Kyushu University Beppu Hospital, Oita, Japan; 2. Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan; 3. Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan; 4. Department of Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; 5. Department of Clinical Laboratory Medicine and Pathology, Kyushu University Beppu Hospital, Beppu, Oita, Japan; 6. Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan; 7. Department of Breast and Endocrine Surgery, Kochi University, Kochi, Japan; 8. Hepato-Biliary-Pancreatic Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan展开收起
PDF源文件 DOI 网页
39 天

Clinicopathological and prognostic features of pancreatic acinar cell carcinoma: a nationwide multicenter study in Japan

作者
Atsushi Kanno; Noriyoshi Fukushima; Naohiro Sata; Kenji Notohara; Masamichi Hayashi; Takaaki Furukawa; Ryota Higuchi; Kosuke Okuwaki; Masayuki Ohtsuka; Toru Watanabe; Kazuhiko Shioji; Toshiya Abe; Hirohisa Kitagawa; Ryuta Muraki; Daisuke Hashimoto; Tomoyuki Satake; Junpei Yamaguchi; Namikatsu Takahara; Jun Nakahodo; Hiroaki Yasuda; Kazuichi Okazaki; Yoshifumi Takeyama; Hiroki Yamaue; Sohei Satoi; Atsushi Masamune展开收起
作者单位
1. Department of Medicine, Division of Gastroenterology, Jichi Medical University, Tochigi, Japan; 2. Department of Pathology, Division of Comprehensive Pathology, Jichi Medical University, Tochigi, Japan; 3. Department of Surgery, Division of Gastroenterological General and Transplant Surgery, Jichi Medical University, Tochigi, Japan; 4. Department of Anatomic Pathology, Kurashiki Central Hospital, Kurashiki, Japan; 5. Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan; 6. Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; 7. Division of Gastroenterological Surgery, Tokyo Women’s Medical University, Yachiyo Medical Center, Yachiyo, Japan; 8. Department of Surgery, Institute of Gastroenterology, Tokyo Women’s Medical University, Tokyo, Japan; 9. Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan; 10. Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan; 11. Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan; 12. Department of Gastroenterology, Niigata Cancer Center Hospital, Niigata, Japan; 13. Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; 14. Department of General Surgery, Kurashiki Central Hospital, Kurashiki, Japan; 15. Imaizumi Hospital, Toyama, Japan; 16. Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan; 17. Department of Gastroenterological Surgery, Shizuoka General Hospital, Shizuoka, Japan; 18. Department of Pancreatobiliary Surgery, Kansai Medical University, Hirakata, Japan; 19. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan; 20. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan; 21. Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan; 22. Department of Gastroenterology in Organ Pathophysiology Program, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; 23. Department of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan; 24. Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; 25. Department of Gastroenterology, Saiseikai Shiga Hospital, Shiga, Japan; 26. Department of Internal Medicine, Kansai Medical University, Kori Hospital, Neyagawa, Japan; 27. Department of Surgery, Kindai University Faculty of Medicine, Osakasayama, Japan; 28. Pancreatic Cancer Center, Department of HPB Surgery, Shonan Kamakura General Hospital, Kanagawa, Japan; 29. Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan; 30. Department of Gastrointestinal Aging Control, Healthspan Research Center, Tohoku University, Sendai, Japan展开收起
PDF源文件 DOI 网页
36 天

Accounting for repeated gastric sampling in autoimmune gastritis

作者
Jiayi Cheng; Zhijing Liu; Chaoyuan Chen展开收起
作者单位
1. Fujian University of Traditional Chinese Medicine, Fuzhou, China; 2. Department of Gastroenterology, Fujian Provincial People’s Hospital, Fuzhou, China展开收起
PDF源文件 DOI 网页
62 天

Annualized fibrosis dynamics in metabolic dysfunction-associated steatotic liver disease: a paired-biopsy cohort

作者
Miwa Kawanaka; Kazuya Miyamoto; Shiho Murakami; Jinpeng Li; Ying Liu; Emi Tanaka; Nozomi Miyake; Takuya Adachi; Yasuto Takeuchi; Hideki Onishi; Ken Nishino; Takashi Fushimi; Noriyo Urata; Hirofumi Kawamoto; Motoyuki Otsuka展开收起
作者单位
1. Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Okayama City, Japan; 2. Department of General Internal Medicine 2, Kawasaki Medical School, Okayama City, Japan展开收起
PDF源文件 DOI 网页
152 天

From trial efficacy to real-world effectiveness: evaluating the generalizability of cisplatin–gemcitabine–durvalumab in advanced biliary tract cancers

作者
Silvia Camera; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Federico Nichetti; Anna Saborowski; Christoph Gerdes; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Frederik Peeters; Chiara Braconi; David J. Pinato; Emiliano Tamburini; Chiara Pircher; Luisa Foltran; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Angela Lamarca; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell’Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Changhoon Yoo; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Su Yung-Yeh; Stephen L. Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Guido Giordano; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Federico Rossari; Federica Lo Prinzi; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Lorenzo Fornaro; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Arndt Vogel; Gianluca Masi; Lorenza Rimassa; Andrea Casadei-Gardini展开收起
作者单位
1. IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy; 2. Vita-Salute San Raffaele University, Milan, Italy; 3. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan; 4. Department of Internal Medicine, Mayo Clinic, Phoenix, USA; 5. Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy; 6. Clinical Oncology Unit, Careggi University Hospital, Florence, Italy; 7. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 8. Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-Si, Republic of Korea; 9. Oncology 1 Unit, Dept of Medical Oncology, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy; 10. Department of Gastroenterology, Hepatology, Infectious Disease and Endocrinology, Hannover Medical School, Hannover, Germany; 11. Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Italy; 12. Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; 13. Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy; 14. Department of Medical Oncology, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) “Dino Amadori”, Meldola, Italy; 15. Digestive Oncology, University Hospitals Leuven, Louvain, Belgium; 16. School of Cancer Sciences, Beatson West Of Scotland Centre, CRUK Scotland Centre, University of Glasgow, Glasgow, UK; 17. Department of Surgery&Cancer, Imperial College London, Hammersmith Hospital, London, UK; 18. Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; 19. Department of Oncology and Palliative Care, Cardinale G. Panico, Tricase City Hospital, Tricase, Italy; 20. Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy; 21. Centro Di Riferimento Oncologico (CRO), IRCCS, National Cancer Institute, Aviano, Italy; 22. Santa Maria Delle Croci Hospital, AUSL, Ravenna, Italy; 23. Department DIMEC, University of Bologna, Bologna, Italy; 24. Upper Gastrointestinal and Endocrine Tumor Unit, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain; 25. Department of Hematology, Oncology and Dermatology, UOC Oncologia A, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy; 26. Clinica Oncologica E Centro Regionale Di Genetica Oncologica, Università Politecnica Delle Marche, Azienda Ospedaliero-Universitaria Delle Marche, Ancona, Italy; 27. Digestive Unit, Champalimaud Clinical Centre, Champalimaud Research Centre, Lisbon, Portugal; 28. Division of Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea; 29. Department of Medical Oncology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain; 30. HealthResearch Institute, Fundacion Jimenez Diaz University Hospital (IIS-FJD), Madrid, Spain; 31. Universidad Autonoma de Madrid (UAM), Madrid, Spain; 32. Medical Oncology and Biomedical Therapy, Policlinico Riuniti, Foggia, Italy; 33. Medical Clinic 1, University Hospital, Goethe-University Frankfurt, Frankfurt Am Main, Germany; 34. Dipartimento Di Oncologia Medica, Fondazione Poliambulanza, Brescia, Italy; 35. Clinical Experimental Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples, Italy; 36. IRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy; 37. Internal Medicine 1, University Hospital Ulm, Ulm, Germany; 38. Institute of Molecular Oncology and Stem Cell Biology, Ulm University Hospital, Ulm, Germany; 39. Division of Oncology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea; 40. Oncologia Medica, Dipartimento Di Medicina Dei Sistemi, Università Di Tor Vergata, Rome, Italy; 41. Department of Medical Oncology, Unidade Local de Saude Do Algarve (ULSAlg), Faro, Portugal; 42. Medical Oncology Unit, University Hospital of Parma, Parma, Italy; 43. Unit of Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 44. Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy; 45. Department of Oncology, University of Turin, San Luigi Hospital, Turin, Italy; 46. Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; 47. Oncology Unit, Ospedale del Mare, Naples, Italy; 48. ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Korea; 49. Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, Viterbo, Italy; 50. Oncology Unit, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy; 51. Medical Oncology, University and University Hospital of Cagliari, Cagliari, Italy; 52. GI Oncology Unit and Familial Cancer Unit, Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; 53. Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, Milan, Italy; 54. Department of Medicine I, Clinical Division of Oncology, Medical University Vienna, Vienna, Austria; 55. Department of Medical Oncology, University Hospital of Udine, Udine, Italy; 56. UOC Oncologia Territoriale, ASL Latina, La Sapienza Università Di Rome, Polo Pontino, Latina, Italy; 57. National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; 58. Department of Internal Medicine, Kaohsiung Medical University Hospital, and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; 59. Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; 60. Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy; 61. Department of Biomedical Sciences, Humanitas University, Milan, Italy; 62. Long Family Chair in Liver Cancer Research, Division of Gastroenterology and Hepatology, Medical Oncology, Princess Margaret Cancer Centre, Toronto General Hospital, Schwartz Reisman Liver Research Centre, Toronto, Canada展开收起
PDF源文件 DOI 网页
1 天

Defining progression timing before risk-adapted surveillance in Barrett’s esophagus

作者
Mengting Chen; Xiaoyan Fu展开收起
作者单位
1. The Second Affiliated People’s Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China展开收起
PDF源文件 DOI 网页

FAQ

JOURNAL OF GASTROENTEROLOGY审稿要多久?

截至2026-11-18,CrushSCI 收录了 JOURNAL OF GASTROENTEROLOGY 的 22 篇完整审稿记录。最快一篇从收稿到录用用了 1 天(Defining progression timing before risk-adapted surveillance in Barrett’s esophagus,2026-08-11 收稿,2026-08-12 录用),最慢一篇用了 375 天;平均 92.0 天,中位数 73.5 天。最快这篇的日期间隔异常短,建议点开原文核对。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。